Full Text (PDF)
Pediatric Education and Research 13(2 (Special Supplement -II)):p 518-520, July-Dec 2025. | DOI: https://doi.org/10.21088/per.2321.1644.13225.131
Review Article
The Contribution of Dr. Jonas Salk to the Field of Paediatrics
Ritika null, Kasumbiwal Ajay H., Lakhe Siddheshwar A., Mundhe Sudarshan R.
Author Information
Licence:
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
Pediatric Education and Research 13(2 (Special Supplement -II)):p 518-520, July-Dec 2025. | DOI: https://doi.org/10.21088/per.2321.1644.13225.131
How Cite This Article:
Kasumbiwal Ajay H., Lakhe Siddheshwar A., Mundhe Sudarshan R., et al. The Contribution of Dr. Jonas Salk to the Field of Paediatrics. Pediatr. Edu. Res. 2025; 13(2): 518-520.Timeline
Received : December 11, 2025
Accepted : December 25, 2025
Published : December 30, 2025
Abstract
Dr. Jonas Edward Salk, an American physician and pioneering virologist, made one of the most transformative contributions to pediatric medicine through the development of the first safe and effective inactivated polio vaccine (IPV). At a time when poliomyelitis caused widespread childhood paralysis and mortality, Salk’s commitment to creating a killed-virus vaccine led to a scientific breakthrough that dramatically changed global public health. His landmark 1954 field trial one of the largest in medical history demonstrated the vaccine’s safety and efficacy, leading to rapid worldwide adoption. The introduction of IPV resulted in an unprecedented decline in polio incidence, protecting millions of children from paralysis and disability. Beyond this achievement, Salk founded the Salk Institute for Biological Studies, which continues to advance research in virology, immunology, and neuroscience. His work overcame scientific skepticism, technical challenges, and public fear, ultimately transforming polio from a dreaded pediatric disease to one nearing global eradication. Salk’s humanitarian legacy, including his refusal to patent the vaccine, remains a cornerstone of modern medical ethics and pediatric healthcare.
References
- 1. Tan S.Y., Ponstein N. Jonas Salk (1914–1995): A vaccine against polio. Singapore medical journal. 2019 Jan; 60(1): 9.
- 2. Kleiss K.M. Dr. Jonas Salk. Primary care update for ob/gyns. 2003 May 1; 10(3): 127-8.
- 3. Sahu H., Choudhari S.G., Gaidhane A., Chakole S. Jonas Salk (1914-1995): Pioneering the fight against polio and beyond. Cureus. 2024 Sep 18; 16(9).
- 4. Valiunas A. Jonas Salk, the people’s scientist. The New Atlantis. 2018 Jul 1(56): 99-128.
- 5. Salk J., Salk J. A new reality: Human evolution for a sustainable future. Simon and Schuster; 2018 Jun 26.
- 6. Beeks J.C. A New Reality: Human Evolution for a Sustainable Future by Jonas Salk and Jonathan Salk: Salk, Jonas, and Jonathan Salk. A New Reality: Human Evolution for a Sustainable Future. Stratford, CT: City Point Press, 2018 (251 pp., $17.10 USD, ISBN: 978-1-947951-04-4).
- 7. Aronson S.M. Jonas Salk, Medical Sleuth and Scientist. Rhode Island Medical Journal. 2020 Aug 1; 103(6): 87-.
- 8. Kluger J. Splendid solution: Jonas Salk and the conquest of polio. Penguin; 2006 Feb 7.
- 9. Salk J.E., Suriano P.C. Importance of Antigenic Composition of Influenza Virus Vaccine in Protecting against the Natural Disease: Observations during the Winter of 1947-1948. American Journal of Public Health and the Nations Health. 1949 Mar; 39(3): 345-55.
Data Sharing Statement
There are no additional data available. All raw data and code are available upon request
Funding
This research received no funding.
Author Contributions
All authors contributed significantly to the work and approve its publication.
Ethics Declaration
This article does not involve any human or animal subjects, and therefore does not require ethics approval.
Acknowledgements
We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.
Conflicts of Interest
No conflicts of interest in this work.
About this article
Cite this article
Kasumbiwal Ajay H., Lakhe Siddheshwar A., Mundhe Sudarshan R., et al. The Contribution of Dr. Jonas Salk to the Field of Paediatrics. Pediatr. Edu. Res. 2025; 13(2): 518-520.
Licence:
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
| Received | Accepted | Published |
|---|---|---|
| December 11, 2025 | December 25, 2025 | December 30, 2025 |
DOI: https://doi.org/10.21088/per.2321.1644.13225.131
Keywords
Jonas SalkInactivated Polio Vaccine (IPV)PoliomyelitisPediatric medicinePublic healthVaccine developmentPolio eradicationSalk InstituteSearch for Similar Articles
Similar Articles
- Contributions of Dr. James A. Hanson in the Field of Paediatrics
- Contribution of Dr. Y.M. Bhende in the Field of Pediatrics
- Contribution of Dr. Nevin S. Scrimshaw in Field of Pediatrics
- Dr. Sidney Farber: Pioneer of Pediatric Oncology and Chemotherapy
- The Contribution of Dr. Yellapragada Subbarao to the Field of Pediatrics
Article Level Metrics
Last UpdatedSaturday 05 September 2026, 22:39:40 (IST)
1860
Accesses
14
192
00
Citations
NA
NA
NA
Download citation
Article Keywords
Keyword Highlighting
Highlight selected keywords in the article text.
Timeline
| Received | December 11, 2025 |
| Accepted | December 25, 2025 |
| Published | December 30, 2025 |
licence
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.